Mackenzie Financial Corp Amgen Inc Transaction History

Mackenzie Financial Corp

$66.8 Billion
Q3 2024

A detailed history of Mackenzie Financial Corp transactions in Amgen Inc stock. As of the latest transaction made, Mackenzie Financial Corp holds 169,838 shares of AMGN stock, worth $48.2 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

169,838

Previous 172,434 1.51%

Holding current value

$48.2 Million

Previous $53.9 Million 1.57%

% of portfolio

0.08%

Previous 0.09%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $803,150 - $875,838	-2,596 Reduced 1.51%	169,838 $54.7 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $7.3 Million - $8.88 Million	-27,798 Reduced 13.88%	172,434 $53.9 Million
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $140,350 - $169,420	522 Added 0.26%	200,232 $56.9 Million
Q4 2023 Jan 30, 2024	BUY	$255.7 - $288.46 $365,395 - $412,209	1,429 Added 0.72%	199,710 $57.5 Million
Q3 2023 Oct 25, 2023	SELL	$218.65 - $271.46 $1.63 Million - $2.03 Million	-7,461 Reduced 3.63%	198,281 $53.3 Million
Q2 2023 Aug 03, 2023	BUY	$214.27 - $253.37 $16.7 Million - $19.8 Million	77,976 Added 61.03%	205,742 $45.7 Million
Q1 2023 Apr 24, 2023	BUY	$225.79 - $275.2 $3.28 Million - $4 Million	14,527 Added 12.83%	127,766 $30.9 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $589,065 - $748,477	2,572 Added 2.32%	113,239 $29.7 Million
Q3 2022 Oct 07, 2022	SELL	$224.46 - $253.15 $490,445 - $553,132	-2,185 Reduced 1.94%	110,667 $24.9 Million
Q2 2022 Aug 10, 2022	SELL	$230.71 - $256.74 $365,213 - $406,419	-1,583 Reduced 1.38%	112,852 $27.5 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $52,624 - $58,216	240 Added 0.21%	114,435 $27.7 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $5.5 Million - $6.29 Million	-27,631 Reduced 19.48%	114,195 $25.7 Million
Q3 2021 Nov 08, 2021	BUY	$212.27 - $248.7 $3.29 Million - $3.85 Million	15,477 Added 12.25%	141,826 $30.2 Million
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $14.5 Million - $16.1 Million	-62,258 Reduced 33.01%	126,349 $30.8 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $71.1 Million - $82.9 Million	-320,560 Reduced 62.96%	188,607 $46.9 Million
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $1.95 Million - $2.32 Million	9,008 Added 1.8%	509,167 $117 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $16.9 Million - $18.8 Million	71,991 Added 16.81%	500,159 $127 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $65.1 Million - $79.9 Million	329,135 Added 332.35%	428,168 $101 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $1.61 Million - $2.14 Million	8,840 Added 9.8%	99,033 $20.1 Million
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $1.12 Million - $1.44 Million	5,937 Added 7.05%	90,193 $21.7 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $98,894 - $118,496	-568 Reduced 0.67%	84,256 $16.3 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $2.94 Million - $3.45 Million	-17,635 Reduced 17.21%	84,824 $15.6 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $891,327 - $1 Million	-4,928 Reduced 4.59%	102,459 $19.5 Million
Q4 2018 Feb 06, 2019	BUY	$178.4 - $208.25 $12 Million - $14.1 Million	67,472 Added 169.04%	107,387 $20.9 Million
Q3 2018 Nov 15, 2018	SELL	$185.29 - $208.89 $2.16 Million - $2.44 Million	-11,683 Reduced 22.64%	39,915 $8.27 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $6.06 Million - $6.81 Million	-36,525 Reduced 41.45%	51,598 $9.52 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $5.41 Million - $6.32 Million	-31,903 Reduced 26.58%	88,123 $15 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $8.34 Million - $9.32 Million	49,411 Added 69.97%	120,026 $20.9 Million
Q3 2017 Nov 13, 2017	SELL	$167.29 - $191.0 $6.01 Million - $6.87 Million	-35,948 Reduced 33.73%	70,615 $13.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	106,563	106,563 $18.4 Million

Others Institutions Holding AMGN

# of Institutions

3,113

Shares Held

410M

Call Options Held

Put Options Held

6.15M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Amgen Inc Transaction History